The time has come to be proactive in finding a path that can benefit all potential stakeholders, rather than letting other third parties define the system in a way that negatively affects potential outcomes.
CEO, D2 Consulting
Advertisement
Articles by CEO, D2 Consulting
The FDA recently launched one of its first programs following the release of the Trump administration’s new drug price plan.
Advertisement
Latest Updated Articles
Federal Drug Price Plan Rollout and Other Trends to WatchSeptember 11th 2018
Responding Proactively to Antikickback GuidelinesNovember 14th 2018
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Clears First Single-Inhaler Triple Therapy for Asthma
2
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
3
FDA Clears the Way for First Generic Single-Dose Flu Treatment Ahead of 2026 Season
4
Elevating Precision Medicine in Breast Cancer Care
5